Market Currents
The FDA approves Kyprolis to treat patients with multiple myeloma who have received at least two...
-
Friday, July 20, 2012, 12:01 PM ETThe FDA approves Kyprolis to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade and an immunomodulatory therapy. Shares of Onyx (ONXX) remain halted.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
